Home Healthcare Healthcare Services Maternal Mental Health Market

Maternal Mental Health Market Size, Share & Trends Analysis Report By Disease Indication (Postpartum Depression, Dysthymia, Pregnancy and Postpartum General Anxiety, Pregnancy and Postpartum OCD, Birth-Related PTSD, Others), By Treatment (Antidepressants, Interpersonal Psychotherapy (IPT), Cognitive Behavioral Therapy (CBT), Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: June 03, 2026 | Author: Debashree B | Format: | Report Code: SR6669DR | Pages: 110
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. Maternal Mental Health Market, By Disease Indication 2022-2034 (USD MILLION/ Units)
    1. Postpartum Depression
    2. Dysthymia
    3. Pregnancy and Postpartum General Anxiety
    4. Pregnancy and Postpartum OCD
    5. Birth-Related PTSD
    6. Others
  2. Maternal Mental Health Market, By Treatment 2022-2034 (USD MILLION/ Units)
    1. Antidepressants
      1. Selective serotonin reuptake inhibitors (SSRIs)
      2. Tricyclic antidepressants (TCAs)
      3. Others
    2. Interpersonal Psychotherapy (IPT)
    3. Cognitive Behavioral Therapy (CBT)
    4. Others
  3. Regional Maternal Mental Health Market
    1. North America
      1. North America Maternal Mental Health Market By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Postpartum Depression
        2. Dysthymia
        3. Pregnancy and Postpartum General Anxiety
        4. Pregnancy and Postpartum OCD
        5. Birth-Related PTSD
        6. Others
      2. North America Maternal Mental Health Market By Treatment 2022-2034 (USD MILLION/ Units)
        1. Antidepressants
          1. Selective serotonin reuptake inhibitors (SSRIs)
          2. Tricyclic antidepressants (TCAs)
          3. Others
        2. Interpersonal Psychotherapy (IPT)
        3. Cognitive Behavioral Therapy (CBT)
        4. Others
      3. U.S.
        1. Postpartum Depression
        2. Dysthymia
        3. Pregnancy and Postpartum General Anxiety
        4. Pregnancy and Postpartum OCD
        5. Birth-Related PTSD
        6. Others
        7. Antidepressants
          1. Selective serotonin reuptake inhibitors (SSRIs)
          2. Tricyclic antidepressants (TCAs)
          3. Others
        8. Interpersonal Psychotherapy (IPT)
        9. Cognitive Behavioral Therapy (CBT)
        10. Others
      4. Canada
        1. Postpartum Depression
        2. Dysthymia
        3. Pregnancy and Postpartum General Anxiety
        4. Pregnancy and Postpartum OCD
        5. Birth-Related PTSD
        6. Others
        7. Antidepressants
          1. Selective serotonin reuptake inhibitors (SSRIs)
          2. Tricyclic antidepressants (TCAs)
          3. Others
        8. Interpersonal Psychotherapy (IPT)
        9. Cognitive Behavioral Therapy (CBT)
        10. Others
    2. Europe
      1. Europe Maternal Mental Health Market By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Postpartum Depression
        2. Dysthymia
        3. Pregnancy and Postpartum General Anxiety
        4. Pregnancy and Postpartum OCD
        5. Birth-Related PTSD
        6. Others
      2. Europe Maternal Mental Health Market By Treatment 2022-2034 (USD MILLION/ Units)
        1. Antidepressants
          1. Selective serotonin reuptake inhibitors (SSRIs)
          2. Tricyclic antidepressants (TCAs)
          3. Others
        2. Interpersonal Psychotherapy (IPT)
        3. Cognitive Behavioral Therapy (CBT)
        4. Others
      3. U.K.
        1. Postpartum Depression
        2. Dysthymia
        3. Pregnancy and Postpartum General Anxiety
        4. Pregnancy and Postpartum OCD
        5. Birth-Related PTSD
        6. Others
        7. Antidepressants
          1. Selective serotonin reuptake inhibitors (SSRIs)
          2. Tricyclic antidepressants (TCAs)
          3. Others
        8. Interpersonal Psychotherapy (IPT)
        9. Cognitive Behavioral Therapy (CBT)
        10. Others
      4. Germany
        1. Postpartum Depression
        2. Dysthymia
        3. Pregnancy and Postpartum General Anxiety
        4. Pregnancy and Postpartum OCD
        5. Birth-Related PTSD
        6. Others
        7. Antidepressants
          1. Selective serotonin reuptake inhibitors (SSRIs)
          2. Tricyclic antidepressants (TCAs)
          3. Others
        8. Interpersonal Psychotherapy (IPT)
        9. Cognitive Behavioral Therapy (CBT)
        10. Others
      5. France
        1. Postpartum Depression
        2. Dysthymia
        3. Pregnancy and Postpartum General Anxiety
        4. Pregnancy and Postpartum OCD
        5. Birth-Related PTSD
        6. Others
        7. Antidepressants
          1. Selective serotonin reuptake inhibitors (SSRIs)
          2. Tricyclic antidepressants (TCAs)
          3. Others
        8. Interpersonal Psychotherapy (IPT)
        9. Cognitive Behavioral Therapy (CBT)
        10. Others
      6. Spain
        1. Postpartum Depression
        2. Dysthymia
        3. Pregnancy and Postpartum General Anxiety
        4. Pregnancy and Postpartum OCD
        5. Birth-Related PTSD
        6. Others
        7. Antidepressants
          1. Selective serotonin reuptake inhibitors (SSRIs)
          2. Tricyclic antidepressants (TCAs)
          3. Others
        8. Interpersonal Psychotherapy (IPT)
        9. Cognitive Behavioral Therapy (CBT)
        10. Others
      7. Italy
        1. Postpartum Depression
        2. Dysthymia
        3. Pregnancy and Postpartum General Anxiety
        4. Pregnancy and Postpartum OCD
        5. Birth-Related PTSD
        6. Others
        7. Antidepressants
          1. Selective serotonin reuptake inhibitors (SSRIs)
          2. Tricyclic antidepressants (TCAs)
          3. Others
        8. Interpersonal Psychotherapy (IPT)
        9. Cognitive Behavioral Therapy (CBT)
        10. Others
      8. Russia
        1. Postpartum Depression
        2. Dysthymia
        3. Pregnancy and Postpartum General Anxiety
        4. Pregnancy and Postpartum OCD
        5. Birth-Related PTSD
        6. Others
        7. Antidepressants
          1. Selective serotonin reuptake inhibitors (SSRIs)
          2. Tricyclic antidepressants (TCAs)
          3. Others
        8. Interpersonal Psychotherapy (IPT)
        9. Cognitive Behavioral Therapy (CBT)
        10. Others
      9. Nordic
        1. Postpartum Depression
        2. Dysthymia
        3. Pregnancy and Postpartum General Anxiety
        4. Pregnancy and Postpartum OCD
        5. Birth-Related PTSD
        6. Others
        7. Antidepressants
          1. Selective serotonin reuptake inhibitors (SSRIs)
          2. Tricyclic antidepressants (TCAs)
          3. Others
        8. Interpersonal Psychotherapy (IPT)
        9. Cognitive Behavioral Therapy (CBT)
        10. Others
      10. Benelux
        1. Postpartum Depression
        2. Dysthymia
        3. Pregnancy and Postpartum General Anxiety
        4. Pregnancy and Postpartum OCD
        5. Birth-Related PTSD
        6. Others
        7. Antidepressants
          1. Selective serotonin reuptake inhibitors (SSRIs)
          2. Tricyclic antidepressants (TCAs)
          3. Others
        8. Interpersonal Psychotherapy (IPT)
        9. Cognitive Behavioral Therapy (CBT)
        10. Others
      11. Rest of Europe
        1. Postpartum Depression
        2. Dysthymia
        3. Pregnancy and Postpartum General Anxiety
        4. Pregnancy and Postpartum OCD
        5. Birth-Related PTSD
        6. Others
        7. Antidepressants
          1. Selective serotonin reuptake inhibitors (SSRIs)
          2. Tricyclic antidepressants (TCAs)
          3. Others
        8. Interpersonal Psychotherapy (IPT)
        9. Cognitive Behavioral Therapy (CBT)
        10. Others
    3. APAC
      1. APAC Maternal Mental Health Market By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Postpartum Depression
        2. Dysthymia
        3. Pregnancy and Postpartum General Anxiety
        4. Pregnancy and Postpartum OCD
        5. Birth-Related PTSD
        6. Others
      2. APAC Maternal Mental Health Market By Treatment 2022-2034 (USD MILLION/ Units)
        1. Antidepressants
          1. Selective serotonin reuptake inhibitors (SSRIs)
          2. Tricyclic antidepressants (TCAs)
          3. Others
        2. Interpersonal Psychotherapy (IPT)
        3. Cognitive Behavioral Therapy (CBT)
        4. Others
      3. China
        1. Postpartum Depression
        2. Dysthymia
        3. Pregnancy and Postpartum General Anxiety
        4. Pregnancy and Postpartum OCD
        5. Birth-Related PTSD
        6. Others
        7. Antidepressants
          1. Selective serotonin reuptake inhibitors (SSRIs)
          2. Tricyclic antidepressants (TCAs)
          3. Others
        8. Interpersonal Psychotherapy (IPT)
        9. Cognitive Behavioral Therapy (CBT)
        10. Others
      4. Korea
        1. Postpartum Depression
        2. Dysthymia
        3. Pregnancy and Postpartum General Anxiety
        4. Pregnancy and Postpartum OCD
        5. Birth-Related PTSD
        6. Others
        7. Antidepressants
          1. Selective serotonin reuptake inhibitors (SSRIs)
          2. Tricyclic antidepressants (TCAs)
          3. Others
        8. Interpersonal Psychotherapy (IPT)
        9. Cognitive Behavioral Therapy (CBT)
        10. Others
      5. Japan
        1. Postpartum Depression
        2. Dysthymia
        3. Pregnancy and Postpartum General Anxiety
        4. Pregnancy and Postpartum OCD
        5. Birth-Related PTSD
        6. Others
        7. Antidepressants
          1. Selective serotonin reuptake inhibitors (SSRIs)
          2. Tricyclic antidepressants (TCAs)
          3. Others
        8. Interpersonal Psychotherapy (IPT)
        9. Cognitive Behavioral Therapy (CBT)
        10. Others
      6. India
        1. Postpartum Depression
        2. Dysthymia
        3. Pregnancy and Postpartum General Anxiety
        4. Pregnancy and Postpartum OCD
        5. Birth-Related PTSD
        6. Others
        7. Antidepressants
          1. Selective serotonin reuptake inhibitors (SSRIs)
          2. Tricyclic antidepressants (TCAs)
          3. Others
        8. Interpersonal Psychotherapy (IPT)
        9. Cognitive Behavioral Therapy (CBT)
        10. Others
      7. Australia
        1. Postpartum Depression
        2. Dysthymia
        3. Pregnancy and Postpartum General Anxiety
        4. Pregnancy and Postpartum OCD
        5. Birth-Related PTSD
        6. Others
        7. Antidepressants
          1. Selective serotonin reuptake inhibitors (SSRIs)
          2. Tricyclic antidepressants (TCAs)
          3. Others
        8. Interpersonal Psychotherapy (IPT)
        9. Cognitive Behavioral Therapy (CBT)
        10. Others
      8. Taiwan
        1. Postpartum Depression
        2. Dysthymia
        3. Pregnancy and Postpartum General Anxiety
        4. Pregnancy and Postpartum OCD
        5. Birth-Related PTSD
        6. Others
        7. Antidepressants
          1. Selective serotonin reuptake inhibitors (SSRIs)
          2. Tricyclic antidepressants (TCAs)
          3. Others
        8. Interpersonal Psychotherapy (IPT)
        9. Cognitive Behavioral Therapy (CBT)
        10. Others
      9. South East Asia
        1. Postpartum Depression
        2. Dysthymia
        3. Pregnancy and Postpartum General Anxiety
        4. Pregnancy and Postpartum OCD
        5. Birth-Related PTSD
        6. Others
        7. Antidepressants
          1. Selective serotonin reuptake inhibitors (SSRIs)
          2. Tricyclic antidepressants (TCAs)
          3. Others
        8. Interpersonal Psychotherapy (IPT)
        9. Cognitive Behavioral Therapy (CBT)
        10. Others
      10. Rest of Asia-Pacific
        1. Postpartum Depression
        2. Dysthymia
        3. Pregnancy and Postpartum General Anxiety
        4. Pregnancy and Postpartum OCD
        5. Birth-Related PTSD
        6. Others
        7. Antidepressants
          1. Selective serotonin reuptake inhibitors (SSRIs)
          2. Tricyclic antidepressants (TCAs)
          3. Others
        8. Interpersonal Psychotherapy (IPT)
        9. Cognitive Behavioral Therapy (CBT)
        10. Others
    4. Middle East and Africa
      1. Middle East and Africa Maternal Mental Health Market By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Postpartum Depression
        2. Dysthymia
        3. Pregnancy and Postpartum General Anxiety
        4. Pregnancy and Postpartum OCD
        5. Birth-Related PTSD
        6. Others
      2. Middle East and Africa Maternal Mental Health Market By Treatment 2022-2034 (USD MILLION/ Units)
        1. Antidepressants
          1. Selective serotonin reuptake inhibitors (SSRIs)
          2. Tricyclic antidepressants (TCAs)
          3. Others
        2. Interpersonal Psychotherapy (IPT)
        3. Cognitive Behavioral Therapy (CBT)
        4. Others
      3. UAE
        1. Postpartum Depression
        2. Dysthymia
        3. Pregnancy and Postpartum General Anxiety
        4. Pregnancy and Postpartum OCD
        5. Birth-Related PTSD
        6. Others
        7. Antidepressants
          1. Selective serotonin reuptake inhibitors (SSRIs)
          2. Tricyclic antidepressants (TCAs)
          3. Others
        8. Interpersonal Psychotherapy (IPT)
        9. Cognitive Behavioral Therapy (CBT)
        10. Others
      4. Turkey
        1. Postpartum Depression
        2. Dysthymia
        3. Pregnancy and Postpartum General Anxiety
        4. Pregnancy and Postpartum OCD
        5. Birth-Related PTSD
        6. Others
        7. Antidepressants
          1. Selective serotonin reuptake inhibitors (SSRIs)
          2. Tricyclic antidepressants (TCAs)
          3. Others
        8. Interpersonal Psychotherapy (IPT)
        9. Cognitive Behavioral Therapy (CBT)
        10. Others
      5. Saudi Arabia
        1. Postpartum Depression
        2. Dysthymia
        3. Pregnancy and Postpartum General Anxiety
        4. Pregnancy and Postpartum OCD
        5. Birth-Related PTSD
        6. Others
        7. Antidepressants
          1. Selective serotonin reuptake inhibitors (SSRIs)
          2. Tricyclic antidepressants (TCAs)
          3. Others
        8. Interpersonal Psychotherapy (IPT)
        9. Cognitive Behavioral Therapy (CBT)
        10. Others
      6. South Africa
        1. Postpartum Depression
        2. Dysthymia
        3. Pregnancy and Postpartum General Anxiety
        4. Pregnancy and Postpartum OCD
        5. Birth-Related PTSD
        6. Others
        7. Antidepressants
          1. Selective serotonin reuptake inhibitors (SSRIs)
          2. Tricyclic antidepressants (TCAs)
          3. Others
        8. Interpersonal Psychotherapy (IPT)
        9. Cognitive Behavioral Therapy (CBT)
        10. Others
      7. Egypt
        1. Postpartum Depression
        2. Dysthymia
        3. Pregnancy and Postpartum General Anxiety
        4. Pregnancy and Postpartum OCD
        5. Birth-Related PTSD
        6. Others
        7. Antidepressants
          1. Selective serotonin reuptake inhibitors (SSRIs)
          2. Tricyclic antidepressants (TCAs)
          3. Others
        8. Interpersonal Psychotherapy (IPT)
        9. Cognitive Behavioral Therapy (CBT)
        10. Others
      8. Nigeria
        1. Postpartum Depression
        2. Dysthymia
        3. Pregnancy and Postpartum General Anxiety
        4. Pregnancy and Postpartum OCD
        5. Birth-Related PTSD
        6. Others
        7. Antidepressants
          1. Selective serotonin reuptake inhibitors (SSRIs)
          2. Tricyclic antidepressants (TCAs)
          3. Others
        8. Interpersonal Psychotherapy (IPT)
        9. Cognitive Behavioral Therapy (CBT)
        10. Others
      9. Rest of MEA
        1. Postpartum Depression
        2. Dysthymia
        3. Pregnancy and Postpartum General Anxiety
        4. Pregnancy and Postpartum OCD
        5. Birth-Related PTSD
        6. Others
        7. Antidepressants
          1. Selective serotonin reuptake inhibitors (SSRIs)
          2. Tricyclic antidepressants (TCAs)
          3. Others
        8. Interpersonal Psychotherapy (IPT)
        9. Cognitive Behavioral Therapy (CBT)
        10. Others
    5. LATAM
      1. LATAM Maternal Mental Health Market By Disease Indication 2022-2034 (USD MILLION/ Units)
        1. Postpartum Depression
        2. Dysthymia
        3. Pregnancy and Postpartum General Anxiety
        4. Pregnancy and Postpartum OCD
        5. Birth-Related PTSD
        6. Others
      2. LATAM Maternal Mental Health Market By Treatment 2022-2034 (USD MILLION/ Units)
        1. Antidepressants
          1. Selective serotonin reuptake inhibitors (SSRIs)
          2. Tricyclic antidepressants (TCAs)
          3. Others
        2. Interpersonal Psychotherapy (IPT)
        3. Cognitive Behavioral Therapy (CBT)
        4. Others
      3. Brazil
        1. Postpartum Depression
        2. Dysthymia
        3. Pregnancy and Postpartum General Anxiety
        4. Pregnancy and Postpartum OCD
        5. Birth-Related PTSD
        6. Others
        7. Antidepressants
          1. Selective serotonin reuptake inhibitors (SSRIs)
          2. Tricyclic antidepressants (TCAs)
          3. Others
        8. Interpersonal Psychotherapy (IPT)
        9. Cognitive Behavioral Therapy (CBT)
        10. Others
      4. Mexico
        1. Postpartum Depression
        2. Dysthymia
        3. Pregnancy and Postpartum General Anxiety
        4. Pregnancy and Postpartum OCD
        5. Birth-Related PTSD
        6. Others
        7. Antidepressants
          1. Selective serotonin reuptake inhibitors (SSRIs)
          2. Tricyclic antidepressants (TCAs)
          3. Others
        8. Interpersonal Psychotherapy (IPT)
        9. Cognitive Behavioral Therapy (CBT)
        10. Others
      5. Argentina
        1. Postpartum Depression
        2. Dysthymia
        3. Pregnancy and Postpartum General Anxiety
        4. Pregnancy and Postpartum OCD
        5. Birth-Related PTSD
        6. Others
        7. Antidepressants
          1. Selective serotonin reuptake inhibitors (SSRIs)
          2. Tricyclic antidepressants (TCAs)
          3. Others
        8. Interpersonal Psychotherapy (IPT)
        9. Cognitive Behavioral Therapy (CBT)
        10. Others
      6. Chile
        1. Postpartum Depression
        2. Dysthymia
        3. Pregnancy and Postpartum General Anxiety
        4. Pregnancy and Postpartum OCD
        5. Birth-Related PTSD
        6. Others
        7. Antidepressants
          1. Selective serotonin reuptake inhibitors (SSRIs)
          2. Tricyclic antidepressants (TCAs)
          3. Others
        8. Interpersonal Psychotherapy (IPT)
        9. Cognitive Behavioral Therapy (CBT)
        10. Others
      7. Colombia
        1. Postpartum Depression
        2. Dysthymia
        3. Pregnancy and Postpartum General Anxiety
        4. Pregnancy and Postpartum OCD
        5. Birth-Related PTSD
        6. Others
        7. Antidepressants
          1. Selective serotonin reuptake inhibitors (SSRIs)
          2. Tricyclic antidepressants (TCAs)
          3. Others
        8. Interpersonal Psychotherapy (IPT)
        9. Cognitive Behavioral Therapy (CBT)
        10. Others
      8. Rest of LATAM
        1. Postpartum Depression
        2. Dysthymia
        3. Pregnancy and Postpartum General Anxiety
        4. Pregnancy and Postpartum OCD
        5. Birth-Related PTSD
        6. Others
        7. Antidepressants
          1. Selective serotonin reuptake inhibitors (SSRIs)
          2. Tricyclic antidepressants (TCAs)
          3. Others
        8. Interpersonal Psychotherapy (IPT)
        9. Cognitive Behavioral Therapy (CBT)
        10. Others
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.